Related Experiment Videos
Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety
J C Ballenger1, J R Davidson, Y Lecrubier
1Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425-0742, USA.
The Journal of Clinical Psychiatry
|August 26, 1998
Summary
Primary care clinicians should use serotonin selective reuptake inhibitors as first-line pharmacotherapy for panic disorder, with treatment lasting 12 to 24 months. Gradual discontinuation over 4 to 6 months is recommended.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Panic disorder management requires clear clinical guidelines for primary care.
- Evidence-based pharmacotherapy recommendations are essential for effective treatment.
Framework:
- International Consensus Group on Depression and Anxiety developed guidelines.
- Consensus based on review papers and scientific literature.
Implementation:
- Standardized definitions for panic disorder response and remission.
- Serotonin selective reuptake inhibitors (SSRIs) recommended as first-choice pharmacotherapy.
- Treatment duration of 12 to 24 months advised.
Implications:
- Improved clinical practice for panic disorder in primary care settings.
- Recommendations for appropriate pharmacotherapy strategies.
- Guidance on slow pharmacotherapy discontinuation over 4 to 6 months.